Plowing enormous fields of patient records to harvest useful data, Atul Butte, M.D., Ph.D., informatics expert, professor and founder of three data-driven start-up companies, shares how his work harnesses information to shape better patient care strategies.
Computational biologist Keith Robison enters the race to find answers for the COVID-19 crisis armed with more than 20 years of drug development experience that ranges from the discovery of a homolog of one of the most valuable drug targets ever to developing a compound now tied to screening the virus.
A team of San Francisco researchers pull CRISPR technology into the pandemic landscape, launching a new diagnostic that can address needs across a continuum of testing using CRISPR proteins.
Glycobiology is at a pivotal point, driven by urgent needs for carbohydrate structure analysis that can advance initiatives such as development and management of a COVID-19 vaccine. The latest special issue from SLAS Technology, Carbohydrate Structure Analysis: Methods and Applications, reveals new techniques to examine these intricate molecules.
Four tenacious technology developers create innovations for making workflows more efficient, fluent and connected. Learn how they leveraged their SLAS membership through the years to correct their mistakes, build new businesses, learn from their customers' needs and deliver finished instruments and products to an enthusiastic audience, receiving not one but two SLAS New Product Awards.
Members of the SLAS community have stepped up big time at numerous stages to provide scientific expertise, thought leadership and hands-on sweat equity to address global SARS-CoV-2. If we missed you in this two-part snapshot, please let SLAS know what you are up to and we’ll get the word out on SLAS social media channels. You also can join the COVID-19 Resources community on SLAS CONNECTED.
One thing is certain after a non-scientific and quick poll of those in the SLAS community doing their part to address SARS-CoV-2. There has never been a more welcome – and necessary – time for collaborative science, and members of the SLAS community are all in. If we missed you in this two-part snapshot, please let SLAS know what you are up to and we’ll get the word out on SLAS social media channels. You also can join the COVID-19 Resources community on SLAS CONNECTED.
An innovative lab-on-a-particle approach offers the precision of droplet microfluidics using standard laboratory equipment only. Researcher Joe de Rutte anticipates new opportunities for life sciences collaboration as this breakthrough allows researchers to more rapidly develop new biotechnology products. This work earned de Rutte the SLAS Innovation Award at SLAS2020 (San Diego, CA, USA).
A new year means three new incredible leaders join the SLAS Board of Directors. We welcome Sue Crimmin, Ph.D., Ira Hoffman, M.S. and Tim Spicer, Ph.D. to the Board at SLAS2020. Along with six current SLAS Board members, Crimmin, Hoffman and Spicer are committed to keeping SLAS moving forward on its mission to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
